Feasibility and safety of minimally invasive cardiac coronary artery bypass grafting surgery for patients with multivessel coronary artery disease: Early outcome and short-mid-term follow up results

  • Zhi-feng XU ,
  • Yun-peng LING ,
  • Zhong-qi CUI ,
  • hong ZHAO ,
  • Yi-chen GONG ,
  • Yuan-hao FU ,
  • Hang YANG ,
  • Feng WAN
Expand
  • 1. Department of Cardiac Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong, China
    2. Department of Cardiac Surgery, Peking University Third Hospital, Beijing 100191, China

Received date: 2018-03-07

  Online published: 2020-10-15

Abstract

Objective: To explore the feasibility, safety and mid-term outcome of minimally invasive cardiac surgery coronary artery bypass grafting (MICS CABG) surgery. Methods: Data of patients who underwent MICS CABG between November 2015 and November 2017 in Peking University Third Hospital were retrospectively analyzed. Results were compared with the patients who underwent off-pump coronary aortic bypass grafting (OPCABG) surgery over the same period. The two groups were matched in propensity score matching method according to age, gender, left ventricular ejection fraction, body mass index, severity of coronary artery disease, smoking, diabetes mellitus, hypertension, hyperlipidemia, renal insufficiency, history of cerebrovascular accident, and history of chronic obstructive pulmonary disease (COPD). Results: There were 85 patients in MICS CABG group, including 68 males (80.0%) and 17 females (20%), with an average age of (63.8±8.7) years; 451 patients were enrolled in OPCABG group, and 85 patients were matched by propensity score as control group (OPCABG group). There was no significant difference in general clinical characteristics (P>0.05). The average grafts of MICS CABG and OPCABG were 2.35±0.83 and 2.48±0.72 respectively (P=0.284). No conversion to thoracotomy in MICS CABG group or cardiopulmonary bypass in neither group occurred. There was no significant difference in the major adverse cardiovascular events (MACCEs, 1.17% vs. 3.52%), reoperation (2.34 vs. 3.52%), new-onset atrial fibrillation rate (4.70% vs. 3.52%) or new-onset renal insufficiency rate (1.17% vs. 0%) between MICS CABG group and OPCABG group (P>0.05). The operation time in MICS CABG group was longer than that in OPCABG group [(282.8±55.8) min vs. (246.8±56.9) min, P<0.05], while the time of ventilator supporting(16.9 h vs. 29.6 h), hospitalization in ICU [(29.3±20.8) h vs. (51.5±48.3) h] and total hospitalization [(18.3±3.2) d vs. (25.7±4.2) d] in MICS CABG group were shorter than those in OPCABG group (P<0.05). The total patency rate (A+B levels) of MICS CABG was 96.5% after surgery. There was no significant difference in MACCEs rate between the two groups [1.18%(1/85) vs. 3.61%(3/83), P>0.05] in 1-year follow up. Conclusion: The MICS CABG surgery is a safe and feasible procedure with good clinical results in early and mid-term follow-up.

Cite this article

Zhi-feng XU , Yun-peng LING , Zhong-qi CUI , hong ZHAO , Yi-chen GONG , Yuan-hao FU , Hang YANG , Feng WAN . Feasibility and safety of minimally invasive cardiac coronary artery bypass grafting surgery for patients with multivessel coronary artery disease: Early outcome and short-mid-term follow up results[J]. Journal of Peking University(Health Sciences), 2020 , 52(5) : 863 -869 . DOI: 10.19723/j.issn.1671-167X.2020.05.011

References

[1] Yi G, Shine B, Rehman SM, et al. Effect of bilateral internal mammary artery grafts on long-term survival: a meta-analysis approach[J]. Circulation, 2014,130(7):539-545.
[2] Ahn M, Park DW, Lee CW, et al. Comparison of stenting versus bypass surgery according to the completeness of revascularization in severe coronary artery disease: patient-level pooled analysis of the SYNTAX, PRECOMBAT, and BEST trials[J]. JACC Cardiovasc Interv, 2017,10(14):1415-1424.
[3] 郑宝荣, 王联群, 刘建实, 等. 探讨Sino SCORE系统对非体外循环下冠状动脉旁路移植术风险评估的价值[J]. 中国循环杂志, 2013,28(5):375-378.
[4] Kikuchi K, Chen X, Mori M, et al. Perioperative outcomes of off-pump minimally invasive coronary artery bypass grafting with bilateral internal thoracic arteries under direct vision[J]. Interact Cardiovasc Thorac Surg, 2017,24(5):696-701.
[5] Nambiar P, Kumar S, Mittal CM, et al. Minimally invasive coronary artery bypass grafting with bilateral internal thoracic arteries: will this be the future[J]. J Thorac Cardiovasc Surg, 2017,155(1):190-197.
[6] 张希涛, 高杰, 刘岩, 等. 腔镜获取大隐静脉在糖尿病患者心脏不停跳冠状动脉旁路移植术的应用[J]. 中华胸心血管外科杂志, 2016,32(3):159-161.
[7] Chan V, Lapierre H, Sohmer B, et al. Handsewn proximal anastomoses onto the ascending aorta through a small left thoracotomy during minimally invasive multivessel coronary artery bypass grafting: a stepwise approach to safety and reproducibility[J]. Semin Thorac Cardiov Surg, 2012,24(1):79-83.
[8] 杨威, 凌云鹏, 陈彧. 左胸前外侧小切口冠状动脉旁路移植术学习曲线[J]. 中国微创外科杂志, 2015,15(11):990-994.
[9] Dijk DV, Nierich AP, Jansen EWL, et al. Early outcome after off-pump vs. on-pump coronary bypass surgery results from a randomized study[J]. Circulation, 2001,104(15):1761-1766.
[10] Kim YH, Oh HC, Choi JW, et al. No-touch saphenous vein harvesting may improve further the patency of saphenous vein com-posite grafts: early outcomes and 1-year angiographic results[J]. Ann Thorac Surg, 2017,103(5):1489-1497.
[11] Kikuchi K, Une D, Suzuki K, et al. Off-pump minimally invasive coronary artery bypass grafting with a heart positioner: direct retraction for a better exposure[J]. Innovations, 2015,10(5):183-187.
[12] Nambiar P, Mittal C. Minimally invasive coronary bypass using internal thoracic arteries via a left minithoracotomy: “the Nambiar Technique”[J]. Innovations, 2013,8(2):420-426.
[13] 杨俊峰, 顾承雄, 韦华, 等. 非体外循环下双侧乳内动脉Y型桥的冠状动脉旁路移植术125例[J]. 中华外科杂志, 2006,44(22):1529-1531.
[14] Glineur D, Etienne PY, Kuschner CE, et al. Bilateral internal mammary artery Y construct with multiple sequential grafting improves survival compared to bilateral internal mammary artery with additional vein grafts: 10-year experience at 2 different institutions[J]. Eur J Cardio-Thorac, 2017,51(2):368-375.
[15] Kikuchi K, Mori M. Less-invasive coronary artery bypass grafting international landscape and progress[J]. Curr Opin Cardiol, 2017,32(6):715-721.
Outlines

/